PLRZ insider trading
NasdaqCM HealthcarePolyrizon Ltd. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About Polyrizon Ltd.
Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company uses its proprietary technology to develop its products comprising Capture and Contain, a barrier against a range of allergen particulates and viruses; and Trap and Target for nasal delivery of active pharmaceutical ingredients. It also develops PL-14, a nasal allergies blocker; PL-15 for COVID-19; and PL-16 for influenza blockers. Polyrizon Ltd. was incorporated in 2005 is headquartered in Ra'anana, Israel.
Company website: www.polyrizon-biotech.com
PLRZ insider activity at a glance
FilingIQ has scored 6 insider transactions for PLRZ since Mar 30, 2026. The most recent filing in our index is dated Mar 31, 2026.
Across the full history, 0 open-market purchases
and 6 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on PLRZ insider trades is 64.5/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest PLRZ Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for PLRZ?
- FilingIQ tracks 6 Form 4 insider transactions for PLRZ (Polyrizon Ltd.), covering filings from Mar 30, 2026 onwards. 6 of those were filed in the last 90 days.
- Are PLRZ insiders net buyers or net sellers?
- Across the full Form 4 history for PLRZ, 0 transactions (0%) were open-market purchases and 6 (100%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does PLRZ insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is PLRZ in?
- Polyrizon Ltd. (PLRZ) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $12.17M.
Methodology & sources
Every PLRZ insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.